Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

3B-PHARMA : revenue, balance sheet and financial ratios

3B-PHARMA is a French company founded 4 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in PARIS (75012), this company of category PME shows in 2024 a net income positive of 180 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - 3B-PHARMA (SIREN 909458424)
Indicator 2024 2023
Revenue N/C N/C
Net income 179 944 € 203 853 €
EBITDA N/C N/C
Net margin N/C N/C

Revenue and income statement

In 2024, 3B-PHARMA generates positive net income of 180 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2023-2024: 204 k€ -> 180 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

179 944 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 78%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

0.0%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

78.22%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

77.1%

Solvency indicators evolution
3B-PHARMA

Sector positioning

Debt ratio
0.0 2024
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Excellent -31 pts over 2 years

In 2024, the debt ratio of 3B-PHARMA (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
78.22% 2024
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Excellent +44 pts over 2 years

In 2024, the financial autonomy of 3B-PHARMA (78.2%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 240.80. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

240.798

Liquidity indicators evolution
3B-PHARMA

Sector positioning

Liquidity ratio
240.8 2024
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Good

In 2024, the liquidity ratio of 3B-PHARMA (240.80) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Positioning of 3B-PHARMA in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of 3B-PHARMA is estimated at 2 512 151 € (range 1 749 422€ - 3 758 322€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
1749k€ 2512k€ 3758k€
2 512 151 € Range: 1 749 422€ - 3 758 322€
NAF 5 année 2024

Valuation method used

Net Income Multiple
179 944 € × 14.0x = 2 512 151 €
Range: 1 749 422€ - 3 758 322€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare 3B-PHARMA with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about 3B-PHARMA

What is the revenue of 3B-PHARMA ?

The revenue of 3B-PHARMA is not publicly disclosed (confidential accounts filed with INPI).

Is 3B-PHARMA profitable?

Yes, 3B-PHARMA generated a net profit of 180 k€ in 2024.

Where is the headquarters of 3B-PHARMA ?

The headquarters of 3B-PHARMA is located in PARIS (75012), in the department Paris.

Where to find the tax return of 3B-PHARMA ?

The tax return of 3B-PHARMA is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does 3B-PHARMA operate?

3B-PHARMA operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.